FDA NDC Directory · JSON-LD · Markdown
NDC 68462-357 · HUMAN PRESCRIPTION DRUG · CAPSULE, EXTENDED RELEASE
| Labeler / Manufacturer | Glenmark Pharmaceuticals Inc., USA |
|---|---|
| Marketing category | Abbreviated NDA (generic) · App ANDA202868 |
| Dosage form / route | CAPSULE, EXTENDED RELEASE · ORAL |
| Active ingredients | POTASSIUM CHLORIDE (750 mg/1) |
| Marketing started | 20160120 |
| Package count | 3 |
Source: openFDA. Public-domain (CC0).